dialysis adequacy;
end-stage renal disease;
morbidity in dialysis;
kinetic modeling;
D O I:
暂无
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Despite improvements in the delivery of dialysis, morbidity and mortality remain excessively high in end-stage renal disease patients. Multiple lines of evidence suggest that inadequate dialysis is responsible these trends. The limits of our understanding of the influence of dialysis dose on mortality and morbidity are discussed. In that context, the relationship between dialysis dose and nutritional status of dialysis patients is also reviewed. The best marker for adequacy of dialysis is yet to be determined. However, urea as a surrogate for small molecular weight solute clearance, has been demonstrated by many studies to be a parameter of adequacy, both in hemodialysis and peritoneal dialysis populations. The application of kinetic modeling of urea is discussed far hemodialysis. The new insights that will be forthcoming at the conclusion of the National Institute of Health HEMO study should help to define an optimal dose of dialysis.
机构:
Univ Calif Los Angeles, Med Ctr, Div Nephrol, Dept Med,David Geffen Sch Med, Los Angeles, CA 90095 USAUniv Calif Los Angeles, Med Ctr, Div Nephrol, Dept Med,David Geffen Sch Med, Los Angeles, CA 90095 USA
Butman, M
Nissenson, AR
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Med Ctr, Div Nephrol, Dept Med,David Geffen Sch Med, Los Angeles, CA 90095 USAUniv Calif Los Angeles, Med Ctr, Div Nephrol, Dept Med,David Geffen Sch Med, Los Angeles, CA 90095 USA